Primary Care Network

Prevent the Event: Long Term Management of the ACS Patient

In order to receive CME credit for this activity, please enter your name and address as indicated and answer the following questions. Your responses will be recorded and forwarded to Primary Care Network.

Name:
Degree:
Email:
Address:
City:
State:
Zip Code:
Phone:	xxx-xxx-xxxx
Fax:	xxx-xxx-xxxx

Post Test

Please answer the following questions by selecting the response you feel is correct for each question. Completion of this post-test will assist Primary Care Network in the measurement of educational outcomes. Thank you.

1. Current recommendations for utilization of dual antiplatelet therapy include:

A. Unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI)

B. ST-segment elevation myocardial infarction (STEMI)

C. Twelve months therapy following coronary stenting with placement of a drug-eluting stent (DES)

D. Patients at high-risk for primary prevention of ACS

E. A, B, and C

2. For patients with documented coronary artery disease, what is the LDL cholesterol goal?

A. <130 mg/dL

B. <100 mg/dL

C. <70 mg/dL

D. None of the above

3. Following a PCI with drug-eluting stent placement, clopidogrel plus aspirin should be continued for:

A. At least 12 months

B. 6-12 months

C. 3-6 months

D. None of the above

4. The incidence of major bleeding complications with 81 mg. ASA plus 75 mg clopidogrel is less than the incidence of 325 mg ASA alone.

A. True

B. False

5. Randomized, controlled studies that evaluate the effect of good vs. poor patient adherence on mortality have shown that good adherence results in a:

A. 15-20% RR in mortality

B. 20-25% RR in mortality

C. 30-35% RR in mortality

D. 40-45% RR in mortality